Vaccines at Velocity: Evaluating Potential Lives Saved by Earlier Vaccination in the COVID-19 Pandemic
Wiecek, W.; Johnston, D.; Dulka, T.; Toomey, D.; Lewis, E.
Show abstract
Fast development of COVID-19 vaccines likely averted millions of deaths. We estimate how many more lives could have been saved if safe and effective vaccines were available earlier in the pandemic, in particular, before the epidemic waves in winter of 2020. We fit an epidemiological model informed by retrospective data and simulate counterfactual vaccination scenarios for the United Kingdom and the United States in which vaccines are available between 30 and 90 days earlier. We find that up to 1 July 2021 reductions in mortality range from 10,000 to 48,000 in the UK and 53,000 to 130,000 in the US, depending on when vaccinations start. This corresponds to a maximum of 7.1 and 4 deaths averted per 10,000 people in the UK and US respectively, or a reduction in overall deaths of 50% and 32%. We find that our model is sensitive to uncertain vaccine parameters and benefits depend on the time horizon of the analysis. However, the large average reductions we estimate suggests that it is highly cost-effective to make large investments in strategies to expedite vaccine availability.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cost-effectiveness of routine COVID-19 adult vaccination programmes in England 96%
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 96%
- Exploring the role of mass immunisation in influenza pandemic preparedness: a modelling study for the UK context 96%
Similar papers in this journal
- SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study 96%
- Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study 96%
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 96%
Similar papers in this journal
- The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation 94%
- Initial protection against Omicron in children and adolescents by BNT162b2 93%
- Effectiveness of one dose of MVA-BN smallpox vaccine against monkeypox in England using the case-coverage method 92%
Similar papers in this journal
- Epidemiological differences in the impact of COVID-19 vaccination in the United States and China 95%
- Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19 94%
- The potential economic impact of the updated COVID-19 mRNA fall 2023 vaccines in Japan 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.